![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Endocrinol. , 06 February 2025
Sec. Systems Endocrinology
Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1551182
This article is a correction to:
Investigating the mechanisms of resveratrol in the treatment of gouty arthritis through the integration of network pharmacology and metabolics
A Corrigendum on
Investigating the mechanisms of resveratrol in the treatment of gouty arthritis through the integration of network pharmacology and metabolics
By Xu X, Yu D, Wang Y, Jiang X, Lu F and Liu S (2024) Front. Endocrinol. 15:1438405. doi: 10.3389/fendo.2024.1438405
In the published article, there was an error in the author list, and author Donghua Yu was erroneously excluded Co-first author. The corrected author list appears below.
“Xiaomin Xu†, Donghua Yu†, Yu Wang, Xin Jiang, Fang Lu*, Shumin Liu*”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: metabonomics, network pharmacology, gouty arthritis, resveratrol, NF- kappa B, MAPK, stat3, JAK2
Citation: Xu X, Yu D, Wang Y, Jiang X, Lu F and Liu S (2025) Corrigendum: Investigating the mechanisms of resveratrol in the treatment of gouty arthritis through the integration of network pharmacology and metabolics. Front. Endocrinol. 16:1551182. doi: 10.3389/fendo.2025.1551182
Received: 24 December 2024; Accepted: 27 January 2025;
Published: 06 February 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Xu, Yu, Wang, Jiang, Lu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shumin Liu, a2VqaS1saXVAMTYzLmNvbQ==; Fang Lu, bHVmYW5nXzEwMDRAMTYzLmNvbQ==
†These authors share first authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.